| Filed On | Filing |
|---|---|
| 05 Jun 2026 |
Form 3: Rossi Michael A., Interim CFO
No securities owned |
| 06 Jun 2023 |
Form 3: North Run CAPITAL, Lp, 10% owner and 5 others
Holds 1,100,592 shares of Common Stock |
| 13 Jan 2022 |
Form 3: Wong Kendra, Principal Accounting Officer
Holds 7,336 shares of Common Stock |
| 02 Feb 2021 |
Form 3: Weisner Aimee S, Director
No securities owned |
| 02 Feb 2021 |
Form 3: O'Farrell Elizabeth G., Director
No securities owned |
| 17 Sep 2020 |
Form 3: Connaughton Alan B., Chief Operating Officer
Holds 212,026 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Pdl BIOPHARMA, Inc., 10% owner
Holds 8,658,694 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Curtis Nicholas T, Director
Holds 614,963 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Mclaughlin John Peter, Director
No securities owned |
| 17 Sep 2020 |
Form 3: Lindstrom Richard L Md, Director
Holds 171,336 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Link William J Phd, Director
Holds 427,537 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Winer Gary M, Director
Holds 21,190 shares of Common Stock |
| 17 Sep 2020 |
Form 3: Staab Thomas R Ii, Chief Financial Officer
Holds 96,381 shares of Common Stock |
Loading...